• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

BenzaClin Topical Gel (clindamycin 1%- benzoyl peroxide gel 5%)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009

 

Summary View

 

PRECAUTIONS 

Information for Patients
  • hypersensitivity/allergic reactions information

ADVERSE REACTIONS

  • hypersensitivity/allergic reactions information